IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Copernicus Capital Management, LLC

Q4 2019 Holdings

Filed 2020-02-14 | 15 holdings | $19.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$10.5M123,95855.1%
Abbvie Inc(ABBV)COM00287Y109$6.8M76,95735.8%
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$1.7M12,0008.8%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$12.7K57,8150.1%
Bristol Myers Squibb Co(BMY)COM110122108$8.5K132,8320.0%
Cigna Corp New(CI)COM125523100$8.2K40,0000.0%
Iqvia Hldgs Inc(IQV)COM46266C105$6.3K40,5850.0%
Zoetis Inc(ZTS)CL A98978V103$4.0K30,3150.0%
Sientra IncCOM82621J105$3.4K384,8090.0%
Thermo Fisher Scientific Inc(TMO)COM883556102$3.2K9,9590.0%
Fate Therapeutics Inc(FATE)COM31189P102$3.2K161,9770.0%
Tandem Diabetes Care Inc(TNDM)COM NEW875372203$3.0K50,0000.0%
Karuna Therapeutics IncCOM48576A100$2.0K26,0000.0%
Humana Inc(HUM)COM444859102$1.4K3,9420.0%
Illumina Inc(ILMN)COM452327109$1.4K4,3090.0%